申请人:Sankyo Company, Limited
公开号:US06528525B1
公开(公告)日:2003-03-04
Amidocarboxylic acid derivatives of the formula:
wherein R1 represents a hydrogen atom, etc.; R2 represents an alkylene group; R3 represents a hydrogen atom, etc.; R4 represents a hydrogen atom, etc.; X represents a substituted or unsubstituted aryl group, etc.,; Y represents an oxygen atom, etc.; Z represents an alkylene group, etc.; and W represents an alkyl group, etc.; and pharmacologically acceptable salts thereof and pharmacologically acceptable esters thereof are useful as the active ingredient of pharmaceutical compositions. They may be used to treat specified diseases, including diabetes mellitus, hyperlipemia, arteriosclerosis, hypertension, etc.
公式为:其中R1代表氢原子,等等;R2代表烷基团;R3代表氢原子,等等;R4代表氢原子,等等;X代表取代或未取代的芳基团,等等;Y代表氧原子,等等;Z代表烷基团,等等;W代表烷基团,等等;以及其药理学上可接受的盐和药理学上可接受的酯作为药物组合物的活性成分是有用的。它们可用于治疗特定疾病,包括糖尿病、高脂血症、动脉硬化、高血压等。